Skip to main content

Table 2 Patient characteristics and association with dialysis modality

From: Long-term survival and predictors for mortality among dialysis patients in an endemic area for chronic liver disease: a national cohort study in Taiwan

 

PD (n = 761)

HD (n = 11293)

P-value

 

n

(%)

n

(%)

 

Gender

    

0.004

Female

445

(58.50)

5997

(53.10)

 

Male

316

(41.50)

5296

(46.90)

 

Age (years)

    

<0.001

18-44

217

(28.50)

1584

(14.00)

 

45-64

347

(45.60)

5067

(44.90)

 

≥65

197

(25.90)

4642

(41.10)

 

Cause of ESRD

    

<0.001

Non-Diabetes Mellitus

478

(62.80)

5471

(48.40)

 

Diabetes Mellitus

283

(37.20)

5822

(51.60)

 

Baseline Comorbidity

     

Hypertension

    

0.548

No

187

(24.60)

2667

(23.60)

 

Yes

574

(75.40)

8626

(76.40)

 

Congestive Heart Failure

    

<0.001

No

567

(86.30)

9172

(81.20)

 

Yes

104

(13.70)

2121

(18.80)

 

Coronary Artery Disease

    

0.01

No

614

(80.70)

8655

(76.60)

 

Yes

147

(19.30)

2638

(23.40)

 

Cerebrovascular Disease

    

0.002

No

698

(91.70)

9224

(87.90)

 

Yes

63

(8.30)

1369

(12.10)

 

Peripheral Arterial Disease

    

0.152

No

740

(97.20)

10867

(96.20)

 

Yes

21

(2.80)

426

(3.80)

 

Chronic Lung Disease

    

<0.001

No

716

(94.10)

10094

(89.40)

 

Yes

45

(5.90)

1199

(10.60)

 

Liver Cirrhosis

    

0.282

No

721

(94.70)

10590

(93.80)

 

Yes

40

(5.30)

703

(6.20)

 

Cancer

    

0.46

No

741

(97.40)

10831

(95.90)

 

Yes

20

(2.60)

462

(4.10)

 

Dementia

    

0.072

No

757

(99.50)

11150

(98.70)

 

Yes

5

(0.50)

143

(1.30)

 

Hemiplegia or Paraplegia

    

0.785

No

750

(98.60)

11143

(98.70)

 

Yes

11

(1.40)

150

(1.30)

 
  1. PD: Peritoneal dialysis; HD: Hemodialysis; ESRD: End-stage renal disease.